Call Start: 8:30 January 1, 0000 9:21 AM ET
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Q4 2024 Earnings Conference Call
February 27, 2025 8:30 A.M. ET
Company Participants
Melanie Herman - Senior Director of Financial Planning and Analysis
Todd Davis - CEO
Paul Hadden - Senior Vice President of Investments and Business Development
Tavo Espinoza - Chief Financial Officer
Lauren Hay - Vice President of Strategic Planning and Investment Analytics
Conference Call Participants
Matt Hewitt - Craig-Hallum
Joseph Pantginis - H.C. Wainwright
Douglas Miehm - RBC Capital Markets
Trevor Allred - Oppenheimer
Larry Solow - CJS Securities
John Vandermosten - Zack
Melanie Herman
Good morning, everyone, and welcome to Ligand’s Fourth Quarter and Full Year 2024 Earnings Call. During the call today, we will review the financial results we released earlier today and provide commentary on our partner pipeline and business development activity, followed by a question and answer session.
Our earnings release and a link to today's webcast can be found in the investor relations section of our website at ligand.com. With me on the call today are CEO Todd Davis; Paul Hadden, Senior Vice President of Investments and Business Development; Chief Financial Officer, Tavo Espinoza; and Vice President of Strategic Planning and Investment Analytics, Lauren Hay. This call is being recorded and the audio portion will be archived in the investor section of our website. On today's call, we will make forward-looking statements regarding our financial results and other matters related to the company's business.
Please refer to the Safe Harbor statement related to these forward-looking statements, which are subject to risks and uncertainties. We remind you that actual events or results may differ materially from those projected or discussed and that all forward-looking statements are based upon current available information. Ligand assumes no obligation to update these statements. To better understand the risks
- Read more current LGND analysis and news
- View all earnings call transcripts